David Tullar, PA
Payments from drug & device makers
What this record shows
Boston Scientific accounts for 71.3% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $1,546, more than ten times the $102 reported in 2021.
Across 25 payments — averaging $80.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- EMD Serono, Inc.$193
- Biogen$82
- Johnson & Johnson$82
- AbbVie$68
- Sanofi$38
- plus $111 from 5 others
What the payments were for
- Travel & lodging$1,02251%
- Food & beverage$97949%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 7 | $1,427 |
| EMD Serono, Inc. | 6 | $193 |
| Biogen | 1 | $82 |
| Johnson & Johnson | 1 | $82 |
| AbbVie | 3 | $68 |
| Sanofi | 2 | $38 |
| Argenx US, Inc. | 1 | $35 |
| Janssen Scientific Affairs, LLC | 1 | $23 |
| Catalyst Pharmaceuticals, Inc. | 1 | $20 |
| TG Therapeutics, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VERCISE$1,169
- GENERAL DBS$102
How this compares
$2,001 in reported general payments places this provider in the 85th percentile of 51 medical providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RytaryCarbidopa/Levodopa | 50 | $7,875 |
| Rivastigmine | 29 | $5,550 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 99 | $3,914 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 167 | $3,896 |
| Memantine Hcl ErMemantine Hcl | 31 | $1,092 |
| Carbamazepine ErCarbamazepine | 12 | $1,086 |
| Primidone | 51 | $855 |
| Gabapentin | 66 | $673 |
| Amitriptyline Hcl | 49 | $651 |
| Topiramate | 23 | $633 |
| Levetiracetam | 29 | $477 |
| Propranolol Hcl ErPropranolol Hcl | 17 | $470 |
| AmantadineAmantadine Hcl | 11 | $465 |
| Divalproex Sodium | 11 | $352 |
| Donepezil Hcl | 45 | $279 |
Paid to pharmacies, not to this prescriber.
Other medical in Fargo
- Gregory BjorklundFargo$47K
- Angela WagnerFargo$4K
- Debra AndvikFargo$3K
- Catherine GarveyFargo$2K
- Melissa ChristensenFargo$2K
- Dacia EngbergFargo$1K
- Kathryn GrayFargo$1K
- Jamie BrownFargo$968
- Susan HansonFargo$709
- Yan TeschFargo$509
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.